Citigroup Maintains Buy on Xylem, Lowers Price Target to $168

Benzinga Newsdesk www.benzinga.com Negative 59.1%

Neg 59.1% Neu 0% Pos 0%

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $174 to $168.

Comments

No comments yet. Be the first!